Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

ZTSZoetis Inc.

Healthcare·Drug Manufacturers—Specialty & Generic·NYSE·Mkt cap $80.00B
$75.37
-$0.16 (-0.21%) today
IEX feed · not consolidated
Last updated Jul 14, 10:08 AM
46/100 Opportunity
57Risk
35Momentum
30Pullback
65Quality
68Valuation
0Trend
Price & History (up to 5 years)
→
Low 0.00— support · — resistanceHigh 0.00
Technical Indicators
RSI (14)41.8
MACD hist0.56
ATR (14)2.48
SMA 2076.23
SMA 5081.31
SMA 200114.54
Rel volume1.1x
Boll upper80.62
Boll lower71.84
52w high158.26
52w low71.48
5y high236.14
5y low71.48
Hist. vol38%
Max drawdown-54%
Near Five-Year LowWeak MomentumAvoidEntry: Wait for Base Formation
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Zoetis Inc. — Drug Manufacturers—Specialty & Generic company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Weak Setup
Opportunity Score
46/100
Risk Level
Moderate
Best Action
Monitor — wait for base formation

Why: ZTS is trading near recent levels (-0.2% today). Overall, the company is reasonably solid. It is near its five-year low, so the reason for the decline must be examined carefully before assuming value. Short-term momentum is still weak, so confirmation is needed before acting. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context30
Valuation68
Trend0
Momentum35
Pullback30
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward100
Entry Timing55
Sell Risk64
Risk57

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.

Recent Signals
  • Near Five-Year LowZTS is within 5.4% of its 5-year low.